Which Comes First, Nonalcoholic Fatty Liver Disease or Arterial Hypertension?
Julia A. Golubeva, A. F. Sheptulina, A. Yu. Elkina, Ekaterina Liusina, Anton R. Kiselev, Oxana M. Drapkina
Abstract
Non-alcoholic fatty liver disease (NAFLD) and arterial hypertension (AH) are widespread noncommunicable diseases in the global population. Since hypertension and NAFLD are diseases associated with metabolic syndrome, they are often comorbid. In fact, many contemporary published studies confirm the association of these diseases with each other, regardless of whether other metabolic factors, such as obesity, dyslipidemia, and type 2 diabetes mellites, are present. This narrative review considers the features of the association between NAFLD and AH, as well as possible pathophysiological mechanisms.
Topics & Concepts
Metabolic syndromeDyslipidemiaNonalcoholic fatty liver diseaseMedicineFatty liverDiseaseDiabetes mellitusType 2 diabetesInternal medicineObesityPopulationBioinformaticsEndocrinologyBiologyEnvironmental healthLiver Disease Diagnosis and TreatmentDiet, Metabolism, and DiseaseAlcohol Consumption and Health Effects